Categories

Business Ideas
Business Opportunities
Corporate
Home Business
International Business
Management
Online Business
Public Company
Public Relations
Small Business

Popular Articles

Tr(e)ading with caution
Three friends went to college together, became software engineers, went to Silicon Valley, got cushy jobs and, after a few years, decided to become entrepreneurs. Sounds like a run-of-the-mill story? But this is where Tushar Makhija’s story takes a serious turn. It’s common to hear of entrepreneurs struggling to get that one big idea to start a business, but for Makhija and his two other friends, it was simply about taking inspiration from several popular online portals and creating a unique one of their own.

Suven Life's drug discovery achieves milestone
Hyderabad-based biopharmaceutical company Suven Life Sciences Limited announced that its drug discovery collaboration in central nervous system (CNS) disorder with the US-based Eli Lilly and Company yielded a positive outcome with lead declaration leading to a milestone payment to Suven.

News of the day

RBI can hike interest rates: Rangarajan
The Prime Minister"s Economic Advisory Council Chairman C Rangarajan today suggested that the Reserve Bank of India (RBI) could reduce money supply and raise interest rates to tame the rising prices of food articles.
Business Ideas

Ranbaxy gets Canada's nod to mkt anti-hypertension drug

Pharma company Ranbaxy Laboratories today said it has received the final approval of the Canadian drug regulator Therapeutic Products Directorate (TPD) to market and manufacture "Ran-Amlodipine tablets", used in treating hypertensions. - Teva Pharma recalls anti-anxiety drug Propofol - Zenotech wants independent valuation for Daiichi open offer">Zenotech wants independent valuation for Daiichi open offer - Madras HC halts Daiichi"s open offer for Zenotech - Medicine for all - Shasun to invest Rs 100 cr for setting up new Vizag plant - Ranbaxy recalls drug from US mkt The company has got the approval for Ran-Amlodipine (Amlodipine Besylate tablets) in 5 and 10 mg strengths, through its wholly-owned subsidiary Ranbaxy Pharmaceuticals- Canada Inc (RPCI), Gurgaon-based (RPCI) said in a statement. "We look forward to marketing both strengths of Ran-Amlodipine tablets at affordable prices that will be beneficial to both the Canadian healthcare system, and most importantly to Canadian patients," RPCI President Paul Drake said. The total market for Amlodipine Besylate tablets in Canada is 456 million Canadian dollars.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009